Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Titel:
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Auteur:
Ladenstein, Ruth Pötschger, Ulrike Pearson, Andrew D J Brock, Penelope Luksch, Roberto Castel, Victoria Yaniv, Isaac Papadakis, Vassilios Laureys, Geneviève Malis, Josef Balwierz, Walentyna Ruud, Ellen Kogner, Per Schroeder, Henrik de Lacerda, Ana Forjaz Beck-Popovic, Maja Bician, Pavel Garami, Miklós Trahair, Toby Canete, Adela Ambros, Peter F Holmes, Keith Gaze, Mark Schreier, Günter Garaventa, Alberto Vassal, Gilles Michon, Jean Valteau-Couanet, Dominique